PMID: 15216914Jun 26, 2004Paper

Development of new drugs in angiogenesis

Current Drug Targets
Marina ZicheLucia Morbidelli

Abstract

Angiogenesis, the growth of new capillaries from pre-existing vessels, contributes to the development and progression of a variety of physio-pathological conditions. There is growing evidence that anti-angiogenic drugs will improve future therapies of diseases like cancer, rheumatoid arthritis and ocular neovascularisation. Conversely, therapeutic angiogenesis is an important homeostatic response contributing to limit the damage to ischemic tissues. Molecular processes involved in angiogenesis include stimulation of endothelial growth by cytokine production (i.e. vascular endothelial growth factor, VEGF; fibroblast growth factor-2, FGF-2), degradation of extracellular matrix proteins by matrix metalloproteinases (MMPs), and migration of endothelial cells mediated by integrins (cell membrane adhesion molecules). Drugs targeting pathologic angiogenesis have been designed to interfere with any of these steps and are currently undergoing evaluation in early clinical studies. Important therapeutic strategies are: suppression of activity and signaling pathways activated by the major angiogenic regulators like VEGF and FGF-2; inhibition of function of alphav-integrins and MMPs; exploitation of endogenous anti-angiogenic molecules like...Continue Reading

Citations

Jul 21, 2005·Microsurgery·J S IsenbergHenry M Spinelli
May 12, 2007·Zeitschrift für Rheumatologie·B MaurerO Distler
Jan 12, 2013·Pharmaceutical Research·Taiyoun RhimMinhyung Lee
Oct 8, 2013·Protein Expression and Purification·Yuli LinZi-Chun Hua
Sep 3, 2009·Journal of the American Chemical Society·K C NicolaouDavid Y-K Chen
Sep 10, 2011·Tissue Engineering. Part a·Jertta-Riina SarkanenTimo Ylikomi
Apr 20, 2005·Current Opinion in Rheumatology·Allen Anandarajah, Christopher T Ritchlin
Sep 7, 2006·Artificial Life·Robert G AbbottKenneth J Pienta
Sep 29, 2012·Biological & Pharmaceutical Bulletin·Xiaobin YuWei Ge
Nov 16, 2004·Current Opinion in Neurology·Jan Drappatz, Patrick Y Wen
Dec 29, 2004·Leukemia & Lymphoma·Ikuo Kashiwakura, Tsuneo A Takahashi
Oct 4, 2005·Expert Opinion on Biological Therapy·Ian ConstableElizabeth Rakoczy
Aug 19, 2007·Kidney International·A KhwajaM El Nahas
Sep 10, 2010·Progress in Retinal and Eye Research·Yolanda Diebold, Margarita Calonge
Jan 24, 2009·Acta histochemica·Susan A BrooksDebbie M S Hall
Nov 11, 2008·Journal of Ethnopharmacology·Ming-Fang HePaul Pui-Hay But
Apr 20, 2007·Cancer Treatment Reviews·Giuseppe LippiGian Cesare Guidi
Mar 1, 2006·Rheumatic Diseases Clinics of North America·Christopher Ritchlin
Jan 17, 2007·APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica·Mahtab Bahramsoltani, Johanna Plendl
Jul 6, 2013·Advanced Healthcare Materials·David Antonio Cantu, W John Kao
Dec 27, 2005·International Journal of Radiation Oncology, Biology, Physics·Mijung Kwon, Steven K Libutti
Jun 29, 2005·Prostaglandins, Leukotrienes, and Essential Fatty Acids·Iolanda M Fierro
Jun 28, 2005·Journal of Controlled Release : Official Journal of the Controlled Release Society·Raymond M SchiffelersMartin C Woodle
Apr 19, 2005·European Journal of Internal Medicine·R A BadawiL Kalra
May 3, 2006·The American Journal of Pathology·Andrei A KramerovAlexander V Ljubimov
Aug 30, 2005·European Journal of Pharmacology·Yi N YeChi H Cho
Jul 28, 2005·FEMS Microbiology Letters·Shih Chung ChenDanny Ling Wang
Dec 3, 2016·Regenerative Medicine·James Koudy Williams, Karl-Erik Andersson
Feb 1, 2006·Vascular Medicine·Thomas Thum, Johann Bauersachs
Nov 23, 2017·Journal of Nanobiotechnology·Pedro PedrosaPedro V Baptista
Sep 28, 2005·The Journal of Biological Chemistry·Sriparna BagchiLaurie Erb
Jun 24, 2005·The Journal of Immunology : Official Journal of the American Association of Immunologists·Robert D StoutJill Suttles
Dec 31, 2020·International Journal of Molecular Sciences·Anna K PuszkoAleksandra Misicka

❮ Previous
Next ❯

Related Concepts

Related Feeds

Arterial-Venous in Development & Disease

Arterial-venous development may play a crucial role in cardiovascular diseases. Here is the latest research.

Adhesion Molecules in Health and Disease

Cell adhesion molecules are a subset of cell adhesion proteins located on the cell surface involved in binding with other cells or with the extracellular matrix in the process called cell adhesion. In essence, cell adhesion molecules help cells stick to each other and to their surroundings. Cell adhesion is a crucial component in maintaining tissue structure and function. Discover the latest research on adhesion molecule and their role in health and disease here.

Angiogenesis Inhibitors to Treat Cancer

Cancer treatments including angiogenesis inhibitors prevent tumor cells from receiving nutrients and oxygen. Here is the latest research on angiogenesis inhibitors for the treatment of cancer.